FEATURES OF DYSLIPOPROTEINEMIA IN TYPE 2 DIABETES MELLITUS PATIENTS WITH PRIOR MYOCARDIAL INFARCTION
DOI:
https://doi.org/10.21856/j-PEP.2015.1.01Keywords:
type 2 diabetes mellitus, postinfarction cardiosclerosis, dyslipoproteinemiaAbstract
he article presents the results of a study of lipid metabolism in postmyocardial infarction patients with type 2 diabetes mellitus. It was identified atherogenic dyslipoproteinemia characterized by a decrease in high-density lipoprotein cholesterol and its protein apolipoprotein A-1, moderate hypertriglyceridemia, increased levels of low-density lipoprotein, very low-density lipoprotein and apolipoprotein B. The study was found that the combination of postinfarction cardiosclerosis and type 2 diabetes mellitus observed deeper lipid metabolism changes than in isolated during disease. The data shows that the change in indexes such as triglycerides, very low-density lipoprotein and apolipoprotein B is largely determined by the influence of diabetes.
References
Dedov II, Shestakova MV. Algoritmy spetsializirovannoj meditsinskoj pomoshchi bolnym sakharnym diabetom, Moskva, 2013: 120 p.
Dedov II, Melnichenko GA. Endokrinologiya: natsionalnoe rukovodstvo, Moskva, 2008: 1072 p.
Aleksandrov AA, Bondarenko IZ, Kukharenko SS, et al. Saharnyj Diabet 2005; 3:34-38.
Aleksandrov AA. Russkiy Meditsinskiy Zhurnal 2010; 14:879-884.
Hurst RT, Lee RW. Ann Intern Med 2006; 139:824-834.
Aleksandrov AA. Bolezni Serdtsa i Sosudov 2007; 2:4-11.
Malmberg K, Ryden L, Wedel H, et al. Eur Heart J 2005; 26:650-661.
Ryden L, Grant PJ, Anker SD, et al. Eur Heart J 2013; 34:3035-3087.
Mitchenko OI, Lutay MI. DislIpIdemii: diagnostika, profilaktika ta likuvannia. Metodychni rekomendatsii Asotsiatsii kardiologiv Ukrainy, Kyiv, 2011: 48 p.
Friedewald WT, Levy RI, Fredricson DS. Clin Chem 1972; 18:499-502.
Klimov AN, Nikulcheva NG. Lipidy, lipoproteiny i ateroskleroz, Sankt-Peterburg, 1995: 304 p.
Ginsberg HN, Huang LS. J Cardiovasc Risk 2000; 7:325-331.
Collins R, Armitage J, Parish S, et al. Lancet 2003; 361:2005-2016.
Vijayaraghavan K. Lipids in Health and Disease 2010; 9:144-156.
Sorrentino SA, Besler C, Rohrer L, et al. Circulation 2010; 121:110-122.
Brunzell JD, Hokanson JE. Diabetes Care 1999; 22(3):10-13.
Velkov VV. Laboratornaia Diagnostika 2008; 3:56-59.
Erqou S, Thompson A, Di Angelantonio E, et al. J Am Coll Cardiol 2010; 55:2160-2167.
Nordestgaard BG, Chapman MJ, Ray K, et al. Eur Heart J 2010; 31(23):2844-2853.
United Kingdom Prospective Diabetes Study: Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex (UKPDS 27) Diabetes Care 1997; 20:1683-1687.